GlassScriptPhysician profile
Kelli Osborn
NPI 1487032199
$737.18
in general payments reported to CMS, 2019-2025
16 companies · $70.43 in 2025
The $70.43 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $49.03 · 2020: $53.79 · 2021: $249 · 2022: $112 · 2023: $138 · 2024: $65.69 · 2025: $70.43.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $274.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $274.14 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $132.91 | 2021-2025 | |
| Novo Nordisk INC | $95.88 | 2020-2023 | Rybelsus, Ozempic |
| Janssen Pharmaceuticals, INC | $77.57 | 2019-2021 | |
| Bayer Healthcare Pharmaceuticals INC. | $76.28 | 2022-2025 | |
| Pfizer INC. | $68.11 | 2021-2023 | |
| Amgen INC. | $66.08 | 2019-2022 | |
| Lilly USA, LLC | $54.03 | 2021-2023 | Mounjaro |
| Intuitive Surgical, INC. | $27.93 | 2023 | Da Vinci Surgical System |
| Novartis Pharmaceuticals Corporation | $26.67 | 2019-2021 | |
| Exact Sciences Corporation | $22.33 | 2025 | Cologuard Collection Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $20.01 | 2021 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $16.31 | 2021 | |
| Otsuka America Pharmaceutical, INC. | $14.22 | 2024 | Rexulti |
| E.R. Squibb & Sons, L.L.C. | $13.79 | 2021 | |
| Biohaven Pharmaceutical Holding Company LTD. | $13.62 | 2022 |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $11.44 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Kelli Osborn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.